Skip to main content
. 2007 Jul 18;2007(3):CD002739. doi: 10.1002/14651858.CD002739.pub3

Comparison 1. % fall index.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 % fall index in FEV1 ( parallel studies, fixed)(>/=4/52) 3 101 Mean Difference (IV, Fixed, 95% CI) ‐11.74 [‐13.42, ‐10.06]
2 % fall index in FEV1 ( crossover studies) 3   Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 % fall index in FEV1 (crossover studies)(>/=4/52) (BDP100mcg ) 1 50 Mean Difference (IV, Fixed, 95% CI) ‐7.0 [‐14.99, 0.99]
2.2 % fall index in FEV1 (crossover studies) (>/=4/52)(BDP 50mcg ) 1 50 Mean Difference (IV, Fixed, 95% CI) ‐7.10 [‐14.63, 0.43]
2.3 % fall index in FEV1 ( crossover studies) ( single dose ) 2 36 Mean Difference (IV, Fixed, 95% CI) ‐5.59 [‐16.14, 4.96]
3 % fall index in PEF ( crossover studies)( >/= 4/52) 1 36 Mean Difference (IV, Fixed, 95% CI) ‐11.5 [‐20.26, ‐2.74]
4 % fall index in FEV1 (crossover studies, GIV, fixed) 3   % (Random, 95% CI) Subtotals only
4.1 % fall index FEV1 ( crossover studies, GIV, fixed)( >/=4/52)( BDP 50 mcg) 1   % (Random, 95% CI) ‐7.00 [‐13.85, ‐0.15]
4.2 % fall index FEV1 (crossover studies, GIV, fixed) ( single dose) 2   % (Random, 95% CI) ‐5.04 [‐16.55, 6.48]
4.3 % fall index FEV1 (crossover studies,GIV, fixed) (>/=4/52)( BDP 100mcg) 1   % (Random, 95% CI) ‐6.9 [‐12.40, ‐1.40]
5 % fall index PEF (crossover studies, GIV, fixed)( >/= 4/52) 1   % (Fixed, 95% CI) ‐11.5 [‐16.69, ‐6.31]
6 % fall index FEV1 ( parallel studies , random)(>/=4/52) 3 101 Mean Difference (IV, Random, 95% CI) ‐11.70 [‐15.90, ‐7.51]
7 % fall index FEV1 (crossover, GIV, random) 3   % (Random, 95% CI) Subtotals only
7.1 % fall index FEV1 (crossover, GIV, random) ( BDP50 mcg)(>/=4/52) 1   % (Random, 95% CI) ‐7.00 [‐13.85, ‐0.15]
7.2 % fall index FEV1 ( crossover, GIV, random) (BDP 100mcg)(>/=4/52) 1   % (Random, 95% CI) ‐6.9 [‐12.40, ‐1.40]
7.3 % fall FEV1( crossover, GIV, random) (single dose) 2   % (Random, 95% CI) ‐5.04 [‐16.55, 6.48]
8 % fall index PEF ( crossover, GIV, random)(>/=4/52) 1   % (Random, 95% CI) ‐11.5 [‐16.69, ‐6.31]
9 % fall index PEF (crossover studies)(single dose) 1 18 Mean Difference (IV, Fixed, 95% CI) 7.5 [‐12.65, 27.65]
10 % fall index in FEV1 ( parallel studies, fixed)(>/=4/52) 0 0 Odds Ratio (M‐H, Fixed, 95% CI) 0.0 [0.0, 0.0]